Background: Cerebrovascular disease (CVD) may contribute to mild cognitive impairment (MCI).
participants recruited in 1992 (WHICAP I; n ϭ 602) and a cohort recruited between 1999 and 2001 (n ϭ 2,174). The sampling strategies have been described elsewhere. 1 The cohort comprises Hispanic, African American, and non-Hispanic white individuals. Ethnic group was determined by self-report using the 2000 US Census format. Participants are followed at approximately 18-month intervals. The study was approved by the Institutional Review Boards of Columbia Presbyterian Medical Center, Columbia University Health Sciences, and the New York State Psychiatric Institute. All participants provided written consent to participate in this study.
The sample for this study was participants with MRI and MCI data. MRI was obtained in 769 participants. Participants were deemed eligible for MRI if they did not meet criteria for dementia at the visit (2002) (2003) (2004) ) before the second follow-up (2005) (2006) (2007) , when brain imaging was performed. A total of 2,113 participants were eligible for MRI (figure); 2,053 of these were seen at the first follow-up, and 60 of these were not seen during the first follow-up; 269 (12.7%) participants had dementia. Of the remaining 1,841 participants, 769 (41.8%) underwent MRI; 407 (38.0%) of the 1,072 excluded refused participation, 25 (2.3%) were unable to be scheduled, 166 (15.4%) died before they were scheduled for imaging, 191 (17.8%) were lost to follow-up, and 283 (26.3%) had MRI contraindications. Of the 769 persons with MRI, 52 were excluded due to dementia at the time of MRI, and 38 were excluded due to insufficient MCI data, leaving 679 persons in the final sample. In these 679 persons, 38 persons had missing data on APOE 4, 4 had missing data on infarcts, and 16 had missing data on WMH. We compared the demographic characteristics of individuals with MRI (n ϭ 769) to those who refused participation in the MRI study, but otherwise met inclusion criteria (n ϭ 407; table e-1 on the Neurology ® Web site at www.neurology.org).
Those refusing participation were older and more likely to be women. African Americans were more frequent among those with MRI. Education was similar between the 2 groups.
Subject evaluation. Clinical evaluation. At each assessment, each participant underwent an in-person interview of general health and functional ability followed by a semi-structured standardized assessment, including medical history, physical and neurologic examination, and a neuropsychological battery. The diagnosis of dementia was based on standard research criteria 6 and was established using all available information (except the MRI results) gathered from the initial and follow-up assessments and medical records at a consensus conference of physicians, neurologists, neuropsychologists, and psychiatrists. Neuropsychological test performance. Learning and memory was assessed with the Selective Reminding Test (SRT), and recognition from the Benton Visual Retention Test (BVRT). 3 Consistent with standard criteria, 7 for all subtypes of MCI, those considered for MCI were required to have 1) cognitive complaints, 2) objective impairment in at least one cognitive domain based on the average of the scores on the neuropsychological measures within that domain and a 1.5 SD cutoff using normative corrections for age, years of education, ethnicity, and sex, 3) essentially preserved activities of daily living, and 4) no diagnosis of dementia at the consensus conference. The original Petersen criteria, 7 which focus on memory impairment, were expanded to include mutually exclusive subtypes based on cognitive features. Amnestic MCI required memory impairment defined as a score Ͻ1.5 SD below demographically corrected mean on an average composite measure comprising the following learning and memory measures: 1) total recall from the SRT, 2) delayed free recall from the SRT, and 3) recognition from the BVRT, with or without deficits in other cognitive domains. Non-amnestic MCI was demonstrated in the absence of the criterion for memory impairment but in the presence of the following: executive impairment, demonstrated on an average composite measure comprising Letter Fluency, Category Fluency, and the WAIS-R Similarities subtest; language impairment, demonstrated on an average composite measure comprising Boston Naming Test, Boston Diagnostic Aphasia Examination (BDAE) Repetition, and the BDAE Comprehension test; and visuospatial impairment, demonstrated on an average composite score comprising Rosen Drawing and BVRT matching.
Cognitive scores. Composite scores were developed using an exploratory factor analysis approach, with confirmatory factor analysis that tested for invariance of the factor structure across English-and Spanish-speaking participants. 8 An exploratory factor analysis using principal axis factoring and oblique rotation was performed on 15 neuropsychological test score variables in the English-speaking sample only. This factor analysis identified factors of memory, language, processing speed, and visual-spatial ability. Three SRT variables (total recall, delayed recall, and delayed recognition) loaded on the memory factor. The language factor was comprised of the naming total variable, the category and letter fluency tests, the Wechsler Adult Intelligence ScaleRevised (WAIS-R) similarities subtest, and the BDAE repetition and comprehension subtests. The processing speed factor was comprised of the 2 timed sequencing tasks, Color Trails 1 and Color Trails 2. The BVRT recognition and matching variables, the Rosen, and the Identities and Oddities subtest loaded on the visual-spatial ability factor. Z scores for each of the cognitive measures were created and then averaged to create a composite score for each factor.
Covariates. Age was calculated at the time of MRI. Sex was self reported. Education was estimated in years. History of type 2 diabetes was ascertained by self-report or by the use of diabetes medications. Hypertension, heart disease, and smoking were defined by self report. Heart disease included a history of atrial fibrillation, other arrhythmias, congestive heart failure, myocardial infarction, and angina pectoris. Smoking was classified into never, current, and past smoking. History of self-reported stroke was also ascertained. APOE genotypes were determined using a modification of the method described by Hixson and Vernier. 9 We classified persons as homozygous or heterozygous for the APOE 4 allele or not having any 4 allele. MRI protocol. Acquisition. MRI was performed on a 1.5-T Philips Intera scanner at Columbia University Medical Center and transferred electronically to the University of CaliforniaDavis for morphometric analysis (Imaging of Dementia and Aging Laboratory). For measures of total brain volume, ventricular volume, and WMH volume, fluid-attenuated inverse recovery (FLAIR)-weighted images were acquired in the axial orientation.
WMH quantification. User-operated-image analysis was performed on a Sun Microsystems Ultra 5 workstation using the Quantum 6.2 package. WMH volumes were derived on FLAIRweighted images following a 2-step process. 10, 11 The dura mater was manually traced within the cranial vault, including the middle cranial fossa but not the posterior fossa and cerebellum. Intracranial volume was defined as the number of voxels contained within the tracings, multiplied by voxel dimensions and slice thickness. These tracings also defined the border between brain and non-brain elements for removal of the latter.
Nonuniformities in image intensity were removed 12 and two Gaussian probability functions, representing brain matter and CSF, were fitted to the skull-stripped image.
12 Once brain matter was isolated, a single Gaussian distribution was fitted to image data and a segmentation threshold for WMH was set a priori at 3.5 SDs in pixel intensity above the mean of the fitted distribution of brain matter. Erosion of 2 exterior image pixels was applied to the brain matter image before modeling to remove partial volume effects and ventricular ependyma on WMH determination. WMH volume was calculated as the sum of voxels greater than or equal to 3.5 SD above the mean intensity value of the image and multiplied by voxel dimensions and slice thickness.
Infarcts. The presence of infarcts was determined according to previously published protocols from the size, location, and imaging characteristics of the lesion. 13 The image analysis system allowed superimposition of the subtraction image, the proton density image, and the T2-weighted image at 3 times magnified view to assist in interpretation of lesion characteristics. Signal void, best seen of T2-weighted image, was interpreted as indicative of a vessel. Only lesions 3 mm or larger qualified as brain infarcts. Infarcts were classified by brain hemisphere (left/right), brain region (28 anatomic regions), and size (small [3 to 9 mm] or large [Ն10 mm]). Previously published Kappa values for agreement among raters have been good, ranging from 0.73 to 0.90.
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Statistical analysis. First, we conducted univariate analyses.
WMH volume was adjusted for total cranial size and expressed as a percentage. The distribution of the adjusted WMH was skewed and required logarithmic transformation. Secondly, we conducted bivariate analyses examining the relation of WMH and infarcts with MCI and its subtypes, amnestic and nonamnestic. We used t test for WMH and 2 for infarcts. Third, we conducted multivariable analyses using logistic regression. In all analyses, MCI and its subtypes were compared to persons with normal cognition. There were separate models for WMH and infarcts. We conducted additional analyses relating WMH and infarcts to cognitive scores using multivariable linear regression. We report 3 models for all multivariable analyses: 1) adjusted for age and gender; 2) additionally adjusted for years of education, ethnic group, and APOE 4 genotype; 3) adjusted for either infarcts or WMH. Model 2 is reported in the text unless other-wise indicated. The rationale for the second model was to adjust for other risk factors and confounders of cognitive impairment, and to explore the independent contribution of WMH or stroke in the third model. Other vascular conditions (diabetes, hypertension, heart disease, stroke history) were not included in the models because they share the pathway relating CVD and MCI. All analyses were conducted using SAS 9.1 for Windows. Table 1 shows the characteristics of the sample. The odds of an infarct increased 3.6 times for each increase in logarithmically transformed adjusted WMH (95% CI: 2.4 -5.3). Only 1 person had more than 1 infarct. Persons with amnestic MCI had a higher proportion of African Americans, a higher proportion of heart disease, and higher WMH (table 2) . Persons with non-amnestic MCI were less educated and had more infarcts.
RESULTS
Relation of WMH to MCI. The adjusted odds of MCI increased with higher WMH (table 3) . This relation was mildly attenuated and became nonsignificant after adjustment for infarcts. A square term for WMH was not statistically significant (p ϭ 0.11), indicating that the relation of WMH and MCI was linear. WMH were more strongly associated with amnestic
Relation of infarcts to MCI. The adjusted odds of MCI increased with the presence of infarcts (table 3) . The OR changed little after adjusting for WMH. This relation was stronger for non-amnestic MCI compared to amnestic MCI. Only the association with non-amnestic MCI remained significant after adjusting for WMH.
Large infarcts were related to amnestic MCI but not non-amnestic MCI (table e-2), although this association was attenuated after adjustment for WMH (OR ϭ 1.6; 95% CI: 0.8, 3.4). Small infarcts were strongly related to non-amnestic MCI, even after adjusting for WMH (OR ϭ 3.3; 95% CI: 1.8, 6.0).
Infarct side was not related to MCI. Analyses of infarct location were limited by small numbers.
Relation of WMH to cognitive domains. WMH were related to memory, speed, and language (table 4). These associations were attenuated after adjusting for infarcts and only the association with language remained statistically significant.
Relation of WMH to memory encoding and retrieval deficits. Our findings linking WMH to amnestic MCI could be explained by memory retrieval deficits, traditionally considered to be the mechanism for amnestic problems in vascular cognitive impairment.
14 Amnestic disorders related to consolidation, more typical of Alzheimer disease (AD) and amnestic MCI, are usually identified by deficits in delayed recall with impaired recognition, while retrieval deficits are characterized by impaired delayed recall with preserved recognition. Delayed recall and total recognition from the SRT were moderately correlated (Pearson coefficient [c] ϭ 0.6; p Ͻ 0.0001), and they were highly correlated with the memory score (c ϭ 0.9 [ p Ͻ 0.0001] and 0.8 [ p Ͻ 0.0001], respectively). Recognition from the BVRT was less strongly correlated with the memory score, SRT delayed recall, and SRT delayed recognition (c ϭ 0.3; p Ͻ 0.0001 for all 3 comparisons). WMH were related similarly to delayed recall (coefficient [r] Ϯ SD ϭ Ϫ0.7 Ϯ 0.2 words; p ϭ 0.004) and recognition (r Ϯ SD ϭ Ϫ0.7 Ϯ 0.2 words; p ϭ 0.004) of the SRT, and recognition of the BVRT (r Ϯ SD ϭ Ϫ0.5 Ϯ 0.2 words; p ϭ 0.01). Thus, our data suggest that WMH in our population is at least partially related to an amnestic impairment profile suggestive of a consolidation deficit.
Relation of infarcts to cognitive domains. Infarcts were related to speed, visuospatial abilities, and language (table 4). The only association that remained DISCUSSION WMH and infarcts on brain MRI were related to MCI. WMH was more strongly related to amnestic MCI than non-amnestic MCI, while infarcts were more strongly related to nonamnestic than amnestic MCI. Supporting these observations, WMH were related to a memory score, while infarcts were not, and the association between infarcts and non-amnestic cognitive scores was stronger than for WMH. WMH was related to word recognition deficits, suggesting that the association between WMH and memory was not completely explained by retrieval deficits. CVD is the main culprit in vascular cognitive impairment, 15 but CVD may be important in AD. CVD alone can result in cognitive impairment, 16 but recent postmortem data suggest that CVD may interact with AD to increase the likelihood of dementia. 17, 18 Infarctions and WMH are 2 CVD manifestations that can be identified during life. 19 Both stroke history 20 and CVD on MRI 21 are related to higher AD risk. MCI is increasingly used in research and clinical practice. MCI has been characterized into subtypes. 2 Amnestic MCI is thought to be more specific to AD, while non-amnestic MCI seems to be related to other causes including CVD.
WMH is related to impairment in frontalexecutive abilities 22 and our finding of a stronger relation between WMH and amnestic MCI was unexpected. A number of studies have previously reported increased WMH in association with MCI. 23, 24 Few studies have explored WMH in relation with MCI subtypes. Most are small and clinic-based. Some studies found an association of WMH with amnestic MCI and AD. 24, 25 Others found that WMH is associated with non-amnestic MCI. 26, 27 One study found no relation between WMH and MCI subtypes. 28 Most studies examining the association of infarcts and MCI are hospital or clinic-based and address MCI following clinical stroke. 15,29 -34 Cognitive impairment after a stroke is frequent, 34 and is characterized by deficits in frontal-executive abilities, 32 but persons with dementia after stroke also demonstrate memory problems. 32 The Cardiovascular Health Study reported an association between infarcts on MRI and amnestic MCI 35 in a large community-based sample.
Our findings suggest that higher WMH is more specific to amnestic than non-amnestic MCI, while infarcts are more specific to non-amnestic MCI. A traditional view is that WMH causes frontalsubcortical pathways disruption resulting in frontalexecutive impairment. 22 WMH in this context are interpreted as an expression of cerebral small vessel disease, 36 possibly of ischemic nature, 37 and are proposed as a surrogate marker of small vessel ischemia. 36 Thus, our findings for WMH seem paradoxical because amnestic MCI is considered an Table 2 Comparison of pertinent characteristics among cognitive categories WMH ϭ white matter hyperintensities; TCV ϭ total cranial volume. Model 1 is adjusted for age and gender. Model 2 is adjusted also for education, ethnic group, and APOE 4. Model 3 is also adjusted for infarcts in the models with WMH as the exposure, and adjusted for WMH in the models with infarcts as the exposure. The normal category is used as the reference for all comparisons. CI ϭ confidence interval.
AD precursor, 2,38 while non-amnestic MCI is commonly associated with vascular disease. However, white matter disease is an important correlate of AD. 39 WMH are frequent in AD 39 and in cerebral amyloid angiopathy (CAA). CAA is related to higher WMH, WMH progression, and cognitive impairment. 40 It is possible that some of the WMH we observed in amnestic MCI are not due to cerebral ischemia but could be part of a process accompanying AD, such as CAA or other neurodegenerative changes. Disruption of frontal subcortical pathways by WMH can result in memory deficits due to retrieval impairment, but we found that WMH were associated with recognition deficits. Finally, it is possible that WMH are entirely ischemic, not related to a degenerative pathology, and they are markers for ischemic insults that precipitate the manifestations of AD, memory impairment, and amnestic MCI. We cannot make inferences about the underlying pathology of WMH in our sample, but our results for WMH could be explained by its heterogeneity. That is, some WMH may be ischemic in nature, and some may be secondary to CAA or other degenerative processes. Thus, we believe that the nature of WMH requires further exploration, and that assuming that they are a surrogate marker of cerebral ischemia and systemic vascular burden may not be accurate.
There are alternative explanations for our findings. The apparent stronger association between WMH or infarcts with either amnestic or nonamnestic MCI could be due to chance due to sample variability and multiple comparisons, or to a lack of power to find statistical significance. Our results need to be reproduced in a larger sample.
Our study has several limitations. One is that we selected a group of elderly individuals without dementia to undergo MRI, which may have excluded persons with a higher CVD burden and cognitive impairment. Another limitation is the cross-sectional study design, which limits the inferences that can be made. Strengths of the study include the quantitative measures of WMH and infarcts, the detailed characterization of MCI, and the large community-based sample. Model 1 is adjusted for age and gender. Model 2 is adjusted also for education, ethnic group, and APOE 4. Model 3 is also adjusted for infarcts in the models with WMH as the exposure, and adjusted for WMH in the models with infarcts as the exposure.
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